Company: CI
Filing Date: 2025-09-02
Form Type: 424B5
Source: 0001140361-25-033574
Chunk: 8

Company: Cigna Group
Filing Date: 2025-09-02
Form: 424B5
Chunk 8
---
 future subordinated indebtedness. The Notes will effectively rank junior to any of our existing and future secured indebtedness to the extent of the assets securing that indebtedness, and will be structurally subordinated to any indebtedness and other liabilities of our subsidiaries. See “Description of the Notes—Ranking.”

<div align='center'>S-2</div>

#### TABLE OF CONTENTS

#### Use of Proceeds
**We estimate that the net proceeds from the issuance and sale of the Notes will be approximately $      , after deducting underwriting discounts and estimated offering expenses. We intend to use the net proceeds from this offering (i) to repay $2.0 billion of loans outstanding under our Term Loan Agreement, dated as of August 5, 2025, among us, the guarantors from time to time party thereto, the banks from time to time party thereto and Bank of America, N.A., as administrative agent (the “Term Loan Facility”), the proceeds of which were used to fund a strategic investment in another company, and (ii) the remainder for general corporate purposes, which may include investments and repayment of indebtedness. See “Use of Proceeds.”

Change of Control-Redemption at the Option of the Holders

A Change of Control Triggering Event will be deemed to occur if both a Change of Control and a Below Investment Grade Rating Event (each as defined under “Description of the Notes—Change of Control Offer”) occur with respect to Notes of any series, in which case, unless we have exercised our right to redeem such Notes as described under “Description of the Notes—Optional Redemption,” we will be required to make an offer to repurchase all of the Notes of such series, at a price equal to 101% of the principal amount of the   -Year Notes, the   -Year Notes, the   -Year Notes or the   -Year Notes, as applicable, plus any accrued and unpaid interest to, but excluding, the date of repurchase. See “Description of the Notes—Change of Control Offer.”**

#### Covenants
The Indenture (as defined herein) for the Notes contains limitations on liens on common stock of our Designated Subsidiaries (as defined in the Indenture) and limits our ability to consolidate with or merge with or into any other person (other than in a merger or consolidation in which we are the surviving person) or sell